Advertisement

Topics

SoftBank Ventures Leads $10M Investment in AI-Driven Drug Discovery Company twoXAR

05:00 EDT 19 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Andreessen Horowitz and OS Fund participate in Series A investment which will be used to build a portfolio of drug programs through biopharmaceutical partnerships twoXAR, Inc., an artificial intelligence (AI)-driven biopharm...

Other Sources for this Article

for twoXAR
Sylvia Aranda, 424-201-9464
saranda@W2OGroup.com

NEXT ARTICLE

More From BioPortfolio on "SoftBank Ventures Leads $10M Investment in AI-Driven Drug Discovery Company twoXAR"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.